PulseAugur
EN
LIVE 22:33:47
中文(ZH) 福泰制药将以约100亿美元交易规模收购Crinetics，创公司史上最大交易

福泰制药以100亿美元收购Crinetics，拓展内分泌业务 · 1 source tracked

By PulseAugur Editorial · [1 sources] ·

福泰制药 (Viatris) has agreed to acquire Crinetics Pharmaceuticals Inc. for approximately $10 billion, marking the largest transaction in the company's history. This acquisition aims to expand Viatris's presence in the endocrinology sector. The deal, valued at $85 per share in cash, represents a 102% premium over Crinetics's closing price and is expected to close in the third quarter, pending regulatory approvals. AI

RANK_REASON Significant acquisition by a major pharmaceutical company. [lever_c_demoted from significant: ic=1 ai=0.0]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

福泰制药以100亿美元收购Crinetics，拓展内分泌业务 · 1 source tracked

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
Significant acquisition by a major pharmaceutical company. [lever_c_demoted from significant: ic=1 ai=0.0]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
funding, product
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
50 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Fosun Pharma to acquire Crinetics for approximately $10 billion, marking the company's largest deal in history

    福泰制药同意收购Crinetics Pharmaceuticals Inc.，以拓展内分泌领域业务。交易对应总股权价值约100亿美元，这将是福泰有史以来规模最大的一笔交易。福泰将以每股85美元现金收购Crinetics，较Crinetics周一收盘价溢价102%。福泰在新闻稿中表示，扣除预计取得的现金后，净交易价值约88亿美元，将在2029年增厚调整后营业利润。该收购已获双方董事会批准，预计将在第三季度完成。（财联社）

RELATED TOPICS